<p>製藥製造商將受益於深厚的專業知識和廣泛的分銷網絡，以及宜瑞安的功能性輔料。</p>
<p>, /PRNewswire/ -- Univar Solutions LLC（&#34;Univar Solutions&#34;或&#34;公司&#34;）是一家領先的全球特種成分和化學品解決方案提供商，今天宣佈其 Ingredients + Specialties 部門被任命為宜瑞安製藥解決方案的分銷商，宜瑞安製藥解決方案是宜瑞安公司（NYSE: INGR）的一部分。該協議包括宜瑞安全球製藥產品組合的分銷，並將公司定位為美國和加拿大製藥澱粉的獨家分銷商。這一戰略合作伙伴關係使 Ingredients + Specialties 能夠進一步多樣化和增強其製藥和營養保健成分組合，提供廣泛的功能性輔料，包括直接壓片和濕法造粒粘合劑、片劑和膠囊的填充劑、超解離劑、潤滑劑、用於包封的乳液以及素食軟膠囊配方的明膠替代品。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919293/Univar_Solutions_Ingredients_and_Specialties.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919293/Univar_Solutions_Ingredients_and_Specialties.jpg"/></p>
<p>我們很高興能夠擴展我們的產品範圍，同時加深與宜瑞安的合作關係。</p>
<p>&#34;我們很高興能夠擴展我們的產品範圍，同時加深與宜瑞安的合作關係，&#34;Univar Solutions 健康與營養全球高級副總裁 Aaron Lee 表示。&#34;通過這項協議，我們將擴大在美國和加拿大對製藥澱粉和其他功能性輔料的獲取，幫助我們的製藥和營養保健客户解決配方挑戰並發展他們的業務。這一合作關係真正體現了我們將客户與高質量成分和定製市場解決方案連接起來的承諾，我們對這一合作能夠提升製片、軟膠囊和包封應用充滿信心。&#34;</p>
<p>宜瑞安製藥解決方案是宜瑞安公司的一部分，宜瑞安是一家全球成分解決方案提供商，生產功能性成分，包括旨在提高配方性能的製藥級澱粉，幫助克服在各種製藥和營養保健應用中遇到的技術挑戰。通過該協議，Univar Solutions 的 Ingredients + Specialties 將分銷宜瑞安的製藥產品組合，並在美國和加拿大獨家分銷基於澱粉的製藥輔料，包括 UNI-PURE® F、UNI-PURE® FL、UNI-PURE® GA 和 UNI-PURE® WG-220。</p>
<p>&#34;我們很高興能夠在製藥澱粉、甘露醇和特種輔料產品領域與 Univar Solutions 的 Ingredients + Specialties 擴展我們的合作關係，&#34;宜瑞安美國和加拿大製藥高級銷售經理 Joe Rogus 表示。&#34;他們是一家世界級組織，在向製藥市場提供高價值特種產品和服務方面擁有出色的業績記錄。我們相信，這一合作將推動成分創新，併為我們的客户提供卓越的價值。&#34;</p>
<p>Univar Solutions 的 Ingredients + Specialties 產品組合是創新和分銷領域最值得信賴的名稱之一，提供品牌和製造商開發新產品和改進產品所需的基本特種成分，以滿足客户的需求。該產品組合得到了他們對創新、可持續性和質量的承諾的支持，以及技術支持和配方專業知識，以幫助確保客户和供應商能夠自信和創造性地應對行業快速變化的未來。</p>
<p>探索 Univar Solutions 的 Ingredients + Specialties 與宜瑞安製藥解決方案之間的關係如何提升配方性能並解決技術挑戰。</p>
<p><strong>關於 Univar Solutions</strong> Univar Solutions 是一家領先的全球特種化學品和成分分銷商，代表來自全球領先生產商的優質產品組合。憑藉行業最大的私人運輸車隊和技術銷售團隊、無與倫比的物流專業知識、深厚的市場和監管知識、配方和配方開發以及領先的數字工具，公司在為廣泛的市場、行業和應用提供量身定製的解決方案和增值服務方面處於良好位置。在履行其幫助保持社區健康、供給、清潔和安全的使命的同時，Univar Solutions 致力於幫助客户和供應商創新，專注於共同成長。瞭解更多信息，請訪問 univarsolutions.com。</p>
<p><strong>關於 Univar Solutions 的 Ingredients + Specialties</strong> Univar Solutions 的 Ingredients + Specialties 為尋求推動現代生活的特種客户和供應商提供最佳產品、人才和成果。通過將科學、創新和深厚的專業知識與領先的特種產品組合相結合，我們幫助找到安全改善全球生活和社區所需的解決方案。瞭解更多信息，請訪問 univarsolutions.com。</p>
<p><strong>關於宜瑞安製藥解決方案</strong></p>
<p>宜瑞安公司（NYSE: INGR）是一家全球創新成分解決方案提供商。對於製藥和營養保健，我們與尋求功能性材料以提高配方性能並克服技術挑戰的客户合作。我們的解決方案包括粘合劑、填充劑、超解離劑、潤滑劑、素食軟膠囊的增塑劑、用於包封的乳液和注射用原料藥。我們正在不斷轉型，結合 cGMP 設施、監管支持、全球存在和技術支持，成為客户值得信賴的配方問題解決合作伙伴。要了解更多信息，請訪問 ingredionpharma.com/。</p>
<p><strong>前瞻性聲明和信息</strong> 本通信包含根據適用法律關於公司業務的財務和運營事項的 “前瞻性聲明”。前瞻性聲明通常可以通過諸如 “相信”、“預計”、“可能”、“將”、“應該”、“能夠”、“尋求”、“打算”、“計劃”、“估計”、“預期” 或其他類似術語來識別。本通信中所作的所有前瞻性聲明均受到此警示性語言的限制。</p>
<p>前瞻性聲明受到已知和未知的風險和不確定性的影響，其中許多可能超出公司的控制範圍，這可能導致預期未能實現，或以其他方式對公司的業務、財務狀況、運營結果或現金流產生重大不利影響。儘管前瞻性聲明是基於管理層認為合理的假設，但我們提醒您，本通信中所呈現的前瞻性信息並不保證未來事件或結果，實際事件或結果可能與本通信中所包含的前瞻性信息所作或暗示的內容有重大差異。有關可能影響公司的因素的更多信息，請參見公司的最新年度報告和其他財務報告，包括 “風險因素” 標題下所列的信息。任何前瞻性聲明僅代表公司在本通信日期的觀點，不應被視為公司在任何後續日期的觀點，公司不承擔任何更新任何前瞻性聲明的義務，除非法律要求。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919294/Ingredion_x_Univar_Solutions.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919294/Ingredion_x_Univar_Solutions.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2352471/Univar_Solutions_LLC_Logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2352471/Univar_Solutions_LLC_Logo.jpg"/></p>
<p>來源：Univar Solutions LLC</p>

宜瑞安

<p>Univar Solutions 已被任命為 Ingredion Pharma Solutions 在美國和加拿大的獨家分銷商。此次合作使 Univar 能夠分銷 Ingredion 的藥用澱粉和功能性輔料，增強其在製藥和營養保健領域的產品組合。該合作旨在解決配方挑戰，並改善客户的產品供應。Univar Solutions 強調其在提供特種成分方面對創新和質量的承諾</p>

<p><em>Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipients</em></p>
<div class="lb-trans"><p>製藥製造商將受益於深厚的專業知識和廣泛的分銷網絡，以及宜瑞安的功能性輔料。</p>
</div><p>, /PRNewswire/ -- Univar Solutions LLC (&#34;Univar Solutions&#34; or &#34;the Company&#34;), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients + Specialties from Univar Solutions division has been appointed as a distributor for Ingredion Pharma Solutions, part of Ingredion Incorporated (NYSE: INGR). The agreement includes distribution of Ingredion's global pharmaceuticals portfolio and positions the Company as the exclusive distributor of pharmaceutical starches in the United States and Canada. This strategic partnership enables Ingredients + Specialties to further diversify and strengthen its pharmaceutical and nutraceutical ingredients portfolios with a broad range of functional excipients, including direct compression and wet granulation binders, fillers for tablets and capsules, superdisintegrants, lubricants, emulsion for encapsulation, and gelatin replacements for vegetarian softgel formulations.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Univar Solutions LLC（&#34;Univar Solutions&#34;或&#34;公司&#34;）是一家領先的全球特種成分和化學品解決方案提供商，今天宣佈其 Ingredients + Specialties 部門被任命為宜瑞安製藥解決方案的分銷商，宜瑞安製藥解決方案是宜瑞安公司（NYSE: INGR）的一部分。該協議包括宜瑞安全球製藥產品組合的分銷，並將公司定位為美國和加拿大製藥澱粉的獨家分銷商。這一戰略合作伙伴關係使 Ingredients + Specialties 能夠進一步多樣化和增強其製藥和營養保健成分組合，提供廣泛的功能性輔料，包括直接壓片和濕法造粒粘合劑、片劑和膠囊的填充劑、超解離劑、潤滑劑、用於包封的乳液以及素食軟膠囊配方的明膠替代品。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919293/Univar_Solutions_Ingredients_and_Specialties.jpg" alt="" original-src="https://mma.prnewswire.com/media/2919293/Univar_Solutions_Ingredients_and_Specialties.jpg"/></p>
<p>We are thrilled to enhance our product range while deepening our partnership with Ingredion.</p>
<div class="lb-trans"><p>我們很高興能夠擴展我們的產品範圍，同時加深與宜瑞安的合作關係。</p>
</div><p>&#34;We are thrilled to enhance our product range while deepening our partnership with Ingredion,&#34; said Aaron Lee, global senior vice president of Health &amp; Nutrition for Univar Solutions. &#34;Through this agreement, we will expand access to pharmaceutical starches and other functional excipients in the United States and Canada, helping our pharmaceutical and nutraceutical customers address formulation challenges and grow their businesses. This partnership truly underscores our commitment connecting customers to high-quality ingredients and customized market solutions, and we are optimistic that the collaboration will help enhance tableting, softgel, and encapsulation applications.&#34;</p>
<div class="lb-trans"><p>&#34;我們很高興能夠擴展我們的產品範圍，同時加深與宜瑞安的合作關係，&#34;Univar Solutions 健康與營養全球高級副總裁 Aaron Lee 表示。&#34;通過這項協議，我們將擴大在美國和加拿大對製藥澱粉和其他功能性輔料的獲取，幫助我們的製藥和營養保健客户解決配方挑戰並發展他們的業務。這一合作關係真正體現了我們將客户與高質量成分和定製市場解決方案連接起來的承諾，我們對這一合作能夠提升製片、軟膠囊和包封應用充滿信心。&#34;</p>
</div><p>Ingredion Pharma Solutions, part of Ingredion, a global ingredient solutions provider, produces functional ingredients, including pharmaceutical-grade starches designed to enhance formulation performance and help overcome the technical challenges experienced in various pharmaceutical and nutraceutical applications. Through the agreement, Ingredients + Specialties from Univar Solutions will distribute Ingredion's pharma portfolio and is the exclusive distributor in the United States and Canada for the Pharma starch-based excipients including UNI-PURE® F, UNI-PURE® FL, UNI-PURE® GA, and UNI-PURE® WG-220.</p>
<div class="lb-trans"><p>宜瑞安製藥解決方案是宜瑞安公司的一部分，宜瑞安是一家全球成分解決方案提供商，生產功能性成分，包括旨在提高配方性能的製藥級澱粉，幫助克服在各種製藥和營養保健應用中遇到的技術挑戰。通過該協議，Univar Solutions 的 Ingredients + Specialties 將分銷宜瑞安的製藥產品組合，並在美國和加拿大獨家分銷基於澱粉的製藥輔料，包括 UNI-PURE® F、UNI-PURE® FL、UNI-PURE® GA 和 UNI-PURE® WG-220。</p>
</div><p>&#34;We are excited to expand our partnership with Ingredients + Specialties from Univar Solutions in the pharmaceutical starches, mannitol, and specialty excipients product space,&#34; said Joe Rogus, pharma senior sales manager – United States and Canada for Ingredion. &#34;They are a world-class organization with an excellent track record in delivering high-value specialty products and services to pharmaceutical markets. We're confident that this collaboration will drive ingredient innovation and deliver exceptional value to our customers.&#34;</p>
<div class="lb-trans"><p>&#34;我們很高興能夠在製藥澱粉、甘露醇和特種輔料產品領域與 Univar Solutions 的 Ingredients + Specialties 擴展我們的合作關係，&#34;宜瑞安美國和加拿大製藥高級銷售經理 Joe Rogus 表示。&#34;他們是一家世界級組織，在向製藥市場提供高價值特種產品和服務方面擁有出色的業績記錄。我們相信，這一合作將推動成分創新，併為我們的客户提供卓越的價值。&#34;</p>
</div><p>The Ingredients + Specialties portfolio from Univar Solutions—one of the most trusted names in innovation and distribution—offers the essential specialty ingredients needed for brands and manufacturers to develop new and improved products that deliver results for their customers. The portfolio is backed by their commitment to innovation, sustainability, and quality, as well as technical support and formulation expertise to help ensure customers and suppliers are equipped to navigate the industry's rapidly changing future with confidence and creativity.</p>
<div class="lb-trans"><p>Univar Solutions 的 Ingredients + Specialties 產品組合是創新和分銷領域最值得信賴的名稱之一，提供品牌和製造商開發新產品和改進產品所需的基本特種成分，以滿足客户的需求。該產品組合得到了他們對創新、可持續性和質量的承諾的支持，以及技術支持和配方專業知識，以幫助確保客户和供應商能夠自信和創造性地應對行業快速變化的未來。</p>
</div><p>Explore how the relationship between Ingredients + Specialties from Univar Solutions and Ingredion Pharma Solutions enhances formulation performance and addresses technical challenges.</p>
<div class="lb-trans"><p>探索 Univar Solutions 的 Ingredients + Specialties 與宜瑞安製藥解決方案之間的關係如何提升配方性能並解決技術挑戰。</p>
</div><p><strong>About Univar Solutions</strong> Univar Solutions is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world's leading producers. With the industry's largest private transportation fleet and technical sales force, unparalleled logistics know-how, deep market and regulatory knowledge, formulation and recipe development, and leading digital tools, the Company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. While fulfilling its purpose to help keep communities healthy, fed, clean, and safe, Univar Solutions is committed to helping customers and suppliers innovate and focus on Growing Together. Learn more at univarsolutions.com.</p>
<div class="lb-trans"><p><strong>關於 Univar Solutions</strong> Univar Solutions 是一家領先的全球特種化學品和成分分銷商，代表來自全球領先生產商的優質產品組合。憑藉行業最大的私人運輸車隊和技術銷售團隊、無與倫比的物流專業知識、深厚的市場和監管知識、配方和配方開發以及領先的數字工具，公司在為廣泛的市場、行業和應用提供量身定製的解決方案和增值服務方面處於良好位置。在履行其幫助保持社區健康、供給、清潔和安全的使命的同時，Univar Solutions 致力於幫助客户和供應商創新，專注於共同成長。瞭解更多信息，請訪問 univarsolutions.com。</p>
</div><p><strong>About Ingredients + Specialties from Univar Solutions</strong> Ingredients + Specialties from Univar Solutions brings the best products, people, and results to specialty customers and suppliers seeking to power modern life. By combining science, innovation, and deep expertise with a leading specialty portfolio, we help find the solutions needed to safely improve lives and communities across the globe. Learn more at univarsolutions.com.</p>
<div class="lb-trans"><p><strong>關於 Univar Solutions 的 Ingredients + Specialties</strong> Univar Solutions 的 Ingredients + Specialties 為尋求推動現代生活的特種客户和供應商提供最佳產品、人才和成果。通過將科學、創新和深厚的專業知識與領先的特種產品組合相結合，我們幫助找到安全改善全球生活和社區所需的解決方案。瞭解更多信息，請訪問 univarsolutions.com。</p>
</div><p><strong>About Ingredion Pharma Solutions</strong></p>
<div class="lb-trans"><p><strong>關於宜瑞安製藥解決方案</strong></p>
</div><p>Ingredion Incorporated (NYSE: INGR) is a global innovative ingredient solutions provider. For Pharma &amp; Nutraceuticals, we partner with customers seeking functional materials to enhance the performance of formulations and overcome their technical challenges. Our solutions include binders, fillers, superdisintegrants, lubricants, plasticizer, gelatine replacers for veggie softgel, emulsions for encapsulation, and parenteral APIs. We are in the continuous transformation to combine cGMP facilities, regulatory assistance, global presence, and technical support to be a trusted formulation problem-solving partner to our customers. To learn more, access ingredionpharma.com/</p>
<div class="lb-trans"><p>宜瑞安公司（NYSE: INGR）是一家全球創新成分解決方案提供商。對於製藥和營養保健，我們與尋求功能性材料以提高配方性能並克服技術挑戰的客户合作。我們的解決方案包括粘合劑、填充劑、超解離劑、潤滑劑、素食軟膠囊的增塑劑、用於包封的乳液和注射用原料藥。我們正在不斷轉型，結合 cGMP 設施、監管支持、全球存在和技術支持，成為客户值得信賴的配方問題解決合作伙伴。要了解更多信息，請訪問 ingredionpharma.com/。</p>
</div><p><strong>Forward-Looking Statements and Information</strong> This communication contains &#34;forward-looking statements&#34; under applicable law regarding financial and operating items relating to the Company's business. Forward-looking statements generally can be identified by words such as &#34;believes,&#34; &#34;expects,&#34; &#34;may,&#34; &#34;will,&#34; &#34;should,&#34; &#34;could,&#34; &#34;seeks,&#34; &#34;intends,&#34; &#34;plans,&#34; &#34;estimates,&#34; &#34;anticipates&#34; or other comparable terms. All forward-looking statements made in this communication are qualified by this cautionary language.</p>
<div class="lb-trans"><p><strong>前瞻性聲明和信息</strong> 本通信包含根據適用法律關於公司業務的財務和運營事項的 “前瞻性聲明”。前瞻性聲明通常可以通過諸如 “相信”、“預計”、“可能”、“將”、“應該”、“能夠”、“尋求”、“打算”、“計劃”、“估計”、“預期” 或其他類似術語來識別。本通信中所作的所有前瞻性聲明均受到此警示性語言的限制。</p>
</div><p>Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control, that could result in expectations not being realized or could otherwise materially and adversely affect the Company's business, financial condition, results of operations or cash flows. Although the forward-looking statements are based on what management believes to be reasonable assumptions, we caution you that the forward-looking information presented in this communication is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this communication. For additional information regarding factors that could affect the Company, please see the Company's most recent annual report and other financial reports, including the information set forth under the caption &#34;Risk Factors.&#34; Any forward-looking statements represent the Company's views only as of the date of this communication and should not be relied upon as representing the Company's views as of any subsequent date, and the Company undertakes no obligation, other than as may be required by law, to update any forward-looking statement.</p>
<div class="lb-trans"><p>前瞻性聲明受到已知和未知的風險和不確定性的影響，其中許多可能超出公司的控制範圍，這可能導致預期未能實現，或以其他方式對公司的業務、財務狀況、運營結果或現金流產生重大不利影響。儘管前瞻性聲明是基於管理層認為合理的假設，但我們提醒您，本通信中所呈現的前瞻性信息並不保證未來事件或結果，實際事件或結果可能與本通信中所包含的前瞻性信息所作或暗示的內容有重大差異。有關可能影響公司的因素的更多信息，請參見公司的最新年度報告和其他財務報告，包括 “風險因素” 標題下所列的信息。任何前瞻性聲明僅代表公司在本通信日期的觀點，不應被視為公司在任何後續日期的觀點，公司不承擔任何更新任何前瞻性聲明的義務，除非法律要求。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919294/Ingredion_x_Univar_Solutions.jpg" alt="" original-src="https://mma.prnewswire.com/media/2919294/Ingredion_x_Univar_Solutions.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2352471/Univar_Solutions_LLC_Logo.jpg" alt="" original-src="https://mma.prnewswire.com/media/2352471/Univar_Solutions_LLC_Logo.jpg"/></p>
<p>SOURCE Univar Solutions LLC</p>
<div class="lb-trans"><p>來源：Univar Solutions LLC</p>
</div>

Univar Solutions 被選定為宜瑞安製藥解決方案在美國和加拿大的分銷商 | INGR 股票新聞